Trial Profile
Effect of Proton Pump Inhibitors on CF Exacerbations
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Cystic fibrosis; Gastro-oesophageal reflux
- Focus Therapeutic Use
- 25 Jan 2022 Status changed from discontinued to completed.
- 13 Apr 2015 Status changed from completed to discontinued, as reported by ClinicalTrials.gov.
- 26 Nov 2013 New trial record